When dosed away from meals, however, only hepatic triglycerides were increased.

Furthermore, lipid analysis revealed increased hepatic triglycerides and MUFAs in B6 and high-fat-fed mice.

Treatment with low-dose ES, short or long-term, alleviated the development of obesity and accumulation of hepatic triglycerides induced by HFD.

Hepatic triglycerides declined from sixfold increase at 8 wk to threefold increase by 36 wk.